Calidi Biotherapeutics Inc. Gains 31.71%
Tue, Jun 11, 2024 at 07:41 PM
Calidi Biotherapeutics Inc. (CLDI:NYSEMKT) shot up at $0.27, a gain of 31.7%. The stock appeared on our News Catalysts scanner on Tue, Jun 11, 2024 at 05:30 PM in the 'MISCELLANEOUS' category. From Tue, May 28, 2024, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Thu, May 30, 2024 at $0.49 with a volume of 9M+.
About Calidi Biotherapeutics Inc. (CLDI:NYSEMKT)
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.
Top 10 Gainers:
- F45 Training Holdings Inc. (FXLV:NYSE), 65.29%
- Trio Petroleum Corp. (TPET:NYSEMKT), 56.35%
- Airship AI Holdings Inc Com (AISP:NASDAQ), 47.13%
- Streamline Health Solutions, Inc. (STRM:NASDAQ), 38.98%
- Blue World Acquisition Corporation (BWAQ:NASDAQ), 34.51%
- TruGolf Inc Cl A (TRUG:NASDAQ), 33.5%
- Selina Hospitality PLC (SLNA:NASDAQ), 33.07%
- Mediaco Holding Inc. (MDIA:NASDAQ), 32.5%
- Calidi Biotherapeutics Inc. (CLDI:NYSEMKT), 31.71%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 30.74%